Life Technologies Reschedules Issuance Of Third Quarter 2012 Performance Report And Associated Conference Call And Webcast to

   Life Technologies Reschedules Issuance Of Third Quarter 2012 Performance
  Report And Associated Conference Call And Webcast to Thursday, November 1,
                2012 Due To Expected Severe Weather Conditions

PR Newswire

CARLSBAD, Calif., Oct. 29, 2012

CARLSBAD, Calif., Oct. 29, 2012 /PRNewswire/ --Life Technologies Corporation
(NASDAQ: LIFE) today announced it is postponing the issuance of its Third
Quarter 2012 earnings release and webcast of a conference call with investment
analysts, which was previously scheduled for Monday, October 29, 2012 at 1:30
p.m. PDT, due to the expected severe weather conditions associated with
Hurricane Sandy.

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

The webcast of a conference call with investment analysts has been rescheduled
for Thursday, November 1, 2012 at 1:30 p.m. PDT.

The webcast can be accessed through the investor relations page of the Life
Technologies website at ir.lifetechnologies.com/events.cfm. A replay of the
webcast will be available on the Company's website through Thursday, November
22, 2012.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company
with customers in more than 160 countries using its innovative solutions to
solve some of today's most difficult scientific challenges. Quality and
innovation are accessible to every lab with its reliable and easy-to-use
solutions spanning the biological spectrum with more than 50,000 products for
agricultural biotechnology, translational research, molecular medicine and
diagnostics, stem cell-based therapies, forensics, food safety and animal
health. Its systems, reagents and consumables represent some of the most cited
brands in scientific research including: Ion Torrent™, Applied Biosystems®,
Invitrogen™, GIBCO®, Ambion®, Molecular Probes®, Novex®, and TaqMan®. Life
Technologies employs approximately 10,400 people and upholds its ongoing
commitment to innovation with more than 4,000 patents and exclusive licenses.
LIFE had sales of $3.7 billion in 2011. Visit us at our website:
http://www.lifetechnologies.com.

Contact Information:
Investor Relations
760-603-7208
ir@lifetech.com

SOURCE Life Technologies Corporation

Website: http://www.lifetechnologies.com
 
Press spacebar to pause and continue. Press esc to stop.